HTG Molecular Number Of Shares Shorted vs. Price To Earning

HTGMDelisted Stock  USD 0.57  0.20  54.05%   
Considering HTG Molecular's profitability and operating efficiency indicators, HTG Molecular Diagnostics may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess HTG Molecular's ability to earn profits and add value for shareholders.
For HTG Molecular profitability analysis, we use financial ratios and fundamental drivers that measure the ability of HTG Molecular to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well HTG Molecular Diagnostics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between HTG Molecular's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of HTG Molecular Diagnostics over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Please note, there is a significant difference between HTG Molecular's value and its price as these two are different measures arrived at by different means. Investors typically determine if HTG Molecular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HTG Molecular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

HTG Molecular Diagnostics Price To Earning vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining HTG Molecular's current stock value. Our valuation model uses many indicators to compare HTG Molecular value to that of its competitors to determine the firm's financial worth.
HTG Molecular Diagnostics is rated below average in number of shares shorted category among its peers. It is rated # 3 in price to earning category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value HTG Molecular by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

HTG Price To Earning vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

HTG Molecular

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
2.73 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

HTG Molecular

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
(0.88) X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

HTG Price To Earning Comparison

HTG Molecular is currently under evaluation in price to earning category among its peers.

HTG Molecular Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in HTG Molecular, profitability is also one of the essential criteria for including it into their portfolios because, without profit, HTG Molecular will eventually generate negative long term returns. The profitability progress is the general direction of HTG Molecular's change in net profit over the period of time. It can combine multiple indicators of HTG Molecular, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. Htg Molecular operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.

HTG Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on HTG Molecular. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of HTG Molecular position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the HTG Molecular's important profitability drivers and their relationship over time.

Use HTG Molecular in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HTG Molecular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HTG Molecular will appreciate offsetting losses from the drop in the long position's value.

HTG Molecular Pair Trading

HTG Molecular Diagnostics Pair Trading Analysis

The ability to find closely correlated positions to HTG Molecular could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HTG Molecular when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HTG Molecular - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HTG Molecular Diagnostics to buy it.
The correlation of HTG Molecular is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HTG Molecular moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HTG Molecular Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HTG Molecular can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your HTG Molecular position

In addition to having HTG Molecular in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Energy ETFs Thematic Idea Now

Energy ETFs
Energy ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 92 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in HTG Stock

If you are still planning to invest in HTG Molecular Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the HTG Molecular's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stocks Directory
Find actively traded stocks across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing